Taburet AM - Search Results

1

Taburet AM, Singlas E. Taburet AM, et al. Clin Pharmacokinet. 1996 May;30(5):385-401. doi: 10.2165/00003088-199630050-00005. Clin Pharmacokinet. 1996. PMID: 8743337 Review.

2

Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients.

Taburet AM, Katlama C, Blanshard C, Zorza G, Gazzard D, Dohin E, Gazzard BG, Frostegard C, Singlas E. Taburet AM, et al. Antimicrob Agents Chemother. 1992 Sep;36(9):1821-4. doi: 10.1128/AAC.36.9.1821. Antimicrob Agents Chemother. 1992. PMID: 1329628 Free PMC article.

3

Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis.

Singlas E, Leroy A, Sultan E, Godin M, Moulin B, Taburet AM, Dhib M, Fillastre JP. Singlas E, et al. Among authors: taburet am. Clin Pharmacokinet. 1990 Jul;19(1):67-79. doi: 10.2165/00003088-199019010-00005. Clin Pharmacokinet. 1990. PMID: 2116256

4

Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients.

Taburet AM, Devillers A, Thomare P, Fillastre JP, Veyssier P, Singlas E. Taburet AM, et al. Clin Pharmacokinet. 1990 Jul;19(1):80-8. doi: 10.2165/00003088-199019010-00006. Clin Pharmacokinet. 1990. PMID: 2116257

5

Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis.

Singlas E, Taburet AM, Borsa Lebas F, Parent de Curzon O, Sobel A, Chauveau P, Viron B, al Khayat R, Poignet JL, Mignon F, et al. Singlas E, et al. Among authors: taburet am. Antimicrob Agents Chemother. 1992 Jul;36(7):1519-24. doi: 10.1128/AAC.36.7.1519. Antimicrob Agents Chemother. 1992. PMID: 1510449 Free PMC article.

6

Theophylline steady state pharmacokinetics is not altered by omeprazole.

Taburet AM, Geneve J, Bocquentin M, Simoneau G, Caulin C, Singlas E. Taburet AM, et al. Eur J Clin Pharmacol. 1992;42(3):343-5. doi: 10.1007/BF00266361. Eur J Clin Pharmacol. 1992. PMID: 1577056 Clinical Trial.

7

Pharmacokinetics of metoclopramide in patients with liver cirrhosis.

Magueur E, Hagege H, Attali P, Singlas E, Etienne JP, Taburet AM. Magueur E, et al. Among authors: taburet am. Br J Clin Pharmacol. 1991 Feb;31(2):185-7. doi: 10.1111/j.1365-2125.1991.tb05511.x. Br J Clin Pharmacol. 1991. PMID: 2049236 Free PMC article.

8

Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation.

Taburet AM, Guibert J, Kitzis MD, Sorensen H, Acar JF, Singlas E. Taburet AM, et al. J Antimicrob Chemother. 1990 Feb;25 Suppl B:23-31. doi: 10.1093/jac/25.suppl_b.23. J Antimicrob Chemother. 1990. PMID: 2312443

9

Pharmacokinetics of zidovudine in patients with liver cirrhosis.

Taburet AM, Naveau S, Zorza G, Colin JN, Delfraissy JF, Chaput JC, Singlas E. Taburet AM, et al. Clin Pharmacol Ther. 1990 Jun;47(6):731-9. doi: 10.1038/clpt.1990.101. Clin Pharmacol Ther. 1990. PMID: 2357867

10

Pharmacokinetics of ornidazole in patients with acute viral hepatitis, alcoholic cirrhosis, and extrahepatic cholestasis.

Taburet AM, Attali P, Bourget P, Etienne JP, Singlas E. Taburet AM, et al. Clin Pharmacol Ther. 1989 Apr;45(4):373-9. doi: 10.1038/clpt.1989.43. Clin Pharmacol Ther. 1989. PMID: 2702794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters